Clinical trial

Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia

NCT00711269

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-06-27

PhasePHASE3

Study timeline

Study start (actual)2008-06-27Date precision: day

Registry last updated2022-04-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Interventions

SM-13496 (lurasidone HCl)DRUG

PlaceboDRUG

RisperidoneDRUG · verified · RxNorm: risperidone

Sponsors & collaborators

Sumitomo Pharma Co., Ltd.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00711269 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.